PHRENILIN®: Each PHRENILIN® tablet for oral administration, contains Butalbital, USP 50 mg, Acetaminophen, USP 325 mg.
PHRENILIN® tablets and PHRENILIN® FORTE capsules are indicated for the relief of the symptom complex of tension (or muscle contraction) headache.
Evidence supporting the efficacy and safety of this combination product in the treatment of multiple recurrent headaches is unavailable. Caution in this regard is required because butalbital is habitforming and potentially abusable.
Media Articles Related to Phrenilin (Butalbital / Acetaminophen)
American Headache Society (AHS) 58th Annual Scientific Meeting
Source: Medscape Headlines [2016.06.17]
Read clinically focused news coverage of key developments from AHS 2016.
Headache: Surprising Headache and Migraine Triggers
Source: MedicineNet Brain Tumor Specialty [2016.06.10]
Title: Headache: Surprising Headache and Migraine Triggers
Created: 5/18/2009 12:00:00 AM
Last Editorial Review: 6/10/2016 12:00:00 AM
Migraine Headaches: 14 Non-Drug Treatments for Migraines
Source: MedicineNet Headache Specialty [2016.06.08]
Title: Migraine Headaches: 14 Non-Drug Treatments for Migraines
Created: 6/25/2012 12:00:00 AM
Last Editorial Review: 6/8/2016 12:00:00 AM
Migraine or Headache? Migraine Symptoms, Triggers, Treatment
Source: MedicineNet Brain Tumor Specialty [2016.05.16]
Title: Migraine or Headache? Migraine Symptoms, Triggers, Treatment
Created: 9/2/2010 11:54:00 AM
Last Editorial Review: 5/16/2016 12:00:00 AM
Surgery for chronic temporal headaches -- simplified approach shows good results
Source: Headache / Migraine News From Medical News Today [2016.05.02]
A modified surgical technique may provide a simpler approach to the surgical treatment for one type of chronic headache, according to an "Ideas and Innovations" paper in the May issue of Plastic and...
Published Studies Related to Phrenilin (Butalbital / Acetaminophen)
Sumatriptan-Naproxen and Butalbital: A Double-Blind, Placebo-Controlled Crossover Study. [2011.11.21]
Objectives.- The primary objective was to compare the efficacy of a sumatriptan and naproxen combination medication (SumaRT/Nap-85 mg sumatriptan and 500 mg naproxen sodium), a butalbital-containing combination medication (BCM-50 mg butalbital, 325 mg acetaminophen, 40 mg caffeine), and placebo when used to treat moderate to severe migraine headache pain in subjects who used BCMs in the past.
Butalbital in the treatment of headache: history, pharmacology, and efficacy. [2001.11]
Analgesics containing butalbital compounded with aspirin, acetaminophen, and/or caffeine are widely used for the treatment of migraine and tension-type headache. The butalbital-containing compounds are efficacious in placebo-controlled trials among patients with episodic tension-type headaches.Because of concerns about overuse, medication-overuse headache, and withdrawal, their use should be limited and carefully monitored.
Page last updated: 2016-06-17